Revisiting IDO and its value as a predictive marker for anti-PD-1 resistance

Botticelli et al. proposed the activity of indoleamine-2,3-dioxygenase 1 (IDO) as a potential mechanism and predictive marker for primary resistance against anti-PD-1 treatment in the context of non-small cell lung cancer. However, there are a few points for the authors to address in order to streng...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Peter Kim, Tran, Stephanie, Minhas, Paras Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339344/
https://www.ncbi.nlm.nih.gov/pubmed/30658666
http://dx.doi.org/10.1186/s12967-019-1784-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339344/
https://www.ncbi.nlm.nih.gov/pubmed/30658666
http://dx.doi.org/10.1186/s12967-019-1784-8

Ejemplares similares